{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:30:21Z","timestamp":1786429821731,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Polish National Science Centre","doi-asserted-by":"crossref","award":["MINIATURA 7: DEC-2023\/07\/X\/NZ6\/00001"],"award-info":[{"award-number":["MINIATURA 7: DEC-2023\/07\/X\/NZ6\/00001"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Polish AIDS Society","award":["The influence of immune depletion receptors PD-1 and PD-1 ligand on the immune reconsti-tution of PLWH."],"award-info":[{"award-number":["The influence of immune depletion receptors PD-1 and PD-1 ligand on the immune reconsti-tution of PLWH."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"DOI":"10.1007\/s12026-026-09817-8","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:06:30Z","timestamp":1786428390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Viral coinfections and checkpoint-marker expression in HIV: An exploratory HCV-Related CD4\u207a T-Cell PD-L1 pattern"],"prefix":"10.1007","volume":"74","author":[{"given":"Bogusz","family":"Aksak-W\u0105s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Skonieczna-\u017bydecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta","family":"Cembrowska-Lech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi\u0142osz","family":"Parczewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u0142","family":"Hrynkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Serwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaja","family":"Mielczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Bruss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franciszek","family":"Lenkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Nied\u017awiedzka-Rystwej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"9817_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/imr.12823","volume":"292","author":"C Fenwick","year":"2019","unstructured":"Fenwick C, Joo V, Jacquier P, et al. T-cell exhaustion in HIV infection. Immunol Rev. 2019;292:149.","journal-title":"Immunol Rev"},{"key":"9817_CR2","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1089\/aid.2020.0106","volume":"36","author":"H Okhai","year":"2020","unstructured":"Okhai H, Vivancos-Gallego MJ, Hill T, Sabin CA. CD4+:CD8+ T cell ratio normalization and the development of AIDS events in people with HIV starting antiretroviral therapy. AIDS Res Hum Retroviruses. 2020;36:808.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"9817_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/QAI.0000000000001013","volume":"73","author":"J Thornhill","year":"2016","unstructured":"Thornhill J, Inshaw J, Kaleebu P, et al. Brief report: enhanced normalization of CD4\/CD8 ratio with earlier antiretroviral therapy at primary HIV infection. J Acquir Immune Defic Syndr. 2016;73:69.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9817_CR4","doi-asserted-by":"crossref","unstructured":"Aksak-W\u0105s B, Skonieczna-\u017bydecka K, Parczewski M, et al. Immunorecovered but Exhausted: Persistent PD-1\/PD-L1 Expression Despite Virologic Suppression and CD4 Recovery in PWH. Biomedicines 2025, Vol 13, Page 1885 2025; 13:1885. Available at: https:\/\/www.mdpi.com\/2227-9059\/13\/8\/1885\/htm. Accessed 3 April 2026","DOI":"10.3390\/biomedicines13081885"},{"key":"9817_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11071887","volume":"11","author":"BJ Aksak-W\u0105s","year":"2022","unstructured":"Aksak-W\u0105s BJ, Urba\u0144ska A, Scheibe K, et al. Factors influencing immune restoration in people living with HIV\/AIDS. J Clin Med. 2022;11:1887.","journal-title":"J Clin Med"},{"key":"9817_CR6","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/hiv.70020","volume":"26","author":"B Aksak-W\u0105s","year":"2025","unstructured":"Aksak-W\u0105s B, Skonieczna-\u017bydecka K, Parczewski M, et al. Rethinking HIV treatment: how non-integrase strand regimens may hold the key to better immune health. HIV Med. 2025;26:879\u201387.","journal-title":"HIV Med"},{"key":"9817_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/jimr\/2462382","author":"B Aksak-W\u0105s","year":"2025","unstructured":"Aksak-W\u0105s B, Skonieczna-\u017bydecka K, Parczewski M, et al. Influence of PD-1 and PD-1L immune exhaustion receptors on immune reconstruction in people living with HIV. J Immunol Res. 2025. https:\/\/doi.org\/10.1155\/jimr\/2462382.","journal-title":"J Immunol Res"},{"key":"9817_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-015-0144-x","volume":"12","author":"V Velu","year":"2015","unstructured":"Velu V, Shetty DD, Larsson M, Shankar EM. Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options. Retrovirology. 2015;12:14.","journal-title":"Retrovirology"},{"key":"9817_CR9","doi-asserted-by":"crossref","unstructured":"Jachymek M, W\u00f3jcik \u0141, Peregud-Pogorzelska M, Parczewski M, Dembowska A, Aksak-W\u0105s BJ. 2024 Cardiovascular Risk in People Living with Human Immunodeficiency (HIV) Viremia Suppression in a Young, Mid-Eastern European Population - Preliminary Study. Vasc Health Risk Manag; 20:435\u2013445. https:\/\/www.dovepress.com\/cardiovascular-risk-in-people-living-with-human-immunodeficiency-hiv-v-peer-reviewed-fulltext-article-VHRM. Accessed 3 April 2026","DOI":"10.2147\/VHRM.S472328"},{"key":"9817_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13020463","volume":"13","author":"M Jachymek","year":"2024","unstructured":"Jachymek M, Peregud-Pogorzelska M, Parczewski M, Dembowska A, W\u00f3jcik \u0141, Aksak-W\u0105s B. Unveiling the heart of the matter: echocardiographic insights into diastolic function and left ventricular and atrial changes in HIV patients with controlled viremia. J Clin Med. 2024;13:463.","journal-title":"J Clin Med"},{"key":"9817_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1013369","volume":"21","author":"K Serwin","year":"2025","unstructured":"Serwin K, Mielczak K, Urba\u0144ska A, et al. Comparison of HIV-1 A6 dispersal dynamics in Poland before and after the war in Ukraine. PLoS Pathog. 2025;21:e1013369.","journal-title":"PLoS Pathog"},{"key":"9817_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/QAI.0000000000002525","volume":"86","author":"M Fabbiani","year":"2021","unstructured":"Fabbiani M, Borghetti A, Squillace N, et al. Integrase inhibitors use and cytomegalovirus infection predict immune recovery in people living with HIV starting first-line therapy. J Acquir Immune Defic Syndr. 2021;86:119\u201327.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9817_CR13","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/cid\/ciw612","volume":"63","author":"DM Smith","year":"2016","unstructured":"Smith DM, Nakazawa M, Freeman ML, et al. Asymptomatic CMV replication during early human immunodeficiency virus (HIV) infection is associated with lower CD4\/CD8 ratio during HIV treatment. Clin Infect Dis. 2016;63:1517.","journal-title":"Clin Infect Dis"},{"key":"9817_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165774","author":"I Poizot-Martin","year":"2016","unstructured":"Poizot-Martin I, Allavena C, Duvivier C, et al. CMV+ serostatus associates negatively with CD4:CD8 ratio normalization in controlled HIV-infected patients on cART. PLoS ONE. 2016. https:\/\/doi.org\/10.1371\/journal.pone.0165774.","journal-title":"PLoS ONE"},{"key":"9817_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15:486\u201399.","journal-title":"Nat Rev Immunol"},{"key":"9817_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","volume":"37","author":"LM McLane","year":"2019","unstructured":"McLane LM, Abdel-Hakeem MS, Wherry EJ. CD8 T cell exhaustion during chronic viral infection and cancer. Annu Rev Immunol. 2019;37:457\u201395.","journal-title":"Annu Rev Immunol"},{"key":"9817_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1086\/432618","volume":"41","author":"MF Miller","year":"2005","unstructured":"Miller MF, Haley C, Koziel MJ, Rowley CF. Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis. Clin Infect Dis. 2005;41:713\u201320.","journal-title":"Clin Infect Dis"},{"key":"9817_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10096-007-0384-3","volume":"27","author":"M Santin","year":"2008","unstructured":"Santin M, Mestre M, Shaw E, et al. Impact of hepatitis C virus coinfection on immune restoration during successful antiretroviral therapy in chronic human immunodeficiency virus type 1 disease. Eur J Clin Microbiol Infect Dis. 2008;27:65\u201373.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"9817_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.726419","author":"ST Gobran","year":"2021","unstructured":"Gobran ST, Ancuta P, Shoukry NH. A tale of two viruses: immunological insights into HCV\/HIV coinfection. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.726419.","journal-title":"Front Immunol"},{"key":"9817_CR20","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/hiv.13612","volume":"25","author":"P Ryscavage","year":"2024","unstructured":"Ryscavage P, Hussien S, Seung H, Hynicka L. CD4+ T-cell recovery in HIV\/hepatitis C co-infected patients following successful hepatitis C treatment. HIV Med. 2024;25:622\u20137.","journal-title":"HIV Med"},{"key":"9817_CR21","unstructured":"Schnittman SR, Hunt PW. CMV and Persistent Immune Activation in HIV. Curr Opin HIV AIDS 2021; 16:168. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8238090\/. Accessed 3 April 2026."},{"key":"9817_CR22","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1093\/infdis\/jit351","volume":"208","author":"G Wandeler","year":"2013","unstructured":"Wandeler G, Gsponer T, Bihl F, et al. Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study. J Infect Dis. 2013;208:1454\u20138.","journal-title":"J Infect Dis"},{"key":"9817_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1089\/aid.2017.0272","volume":"34","author":"L Houghtaling","year":"2018","unstructured":"Houghtaling L, Moh R, Abdou Chekaraou M, et al. CD4+ T cell recovery and hepatitis B virus coinfection in HIV-infected patients from C\u00f4te d\u2019Ivoire initiating antiretroviral therapy. AIDS Res Hum Retroviruses. 2018;34:439\u201345.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"9817_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/QAI.0000000000000142","volume":"66","author":"HM Chun","year":"2014","unstructured":"Chun HM, Mesner O, Thio CL, et al. HIV outcomes in hepatitis B virus coinfected individuals on HAART. J Acquir Immune Defic Syndr. 2014;66:197.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9817_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104773","volume":"95","author":"J Mart\u00ednez-Sanz","year":"2023","unstructured":"Mart\u00ednez-Sanz J, D\u00edaz-\u00c1lvarez J, Rosas M, et al. Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4\/CD8 ratio in predicting non-AIDS events. EBioMedicine. 2023;95:104773.","journal-title":"EBioMedicine"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09817-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-026-09817-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09817-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:06:32Z","timestamp":1786428392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-026-09817-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9817"],"URL":"https:\/\/doi.org\/10.1007\/s12026-026-09817-8","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Bioethical Committee of the Pomeranian Medical University (approval number KB-006\/40\/2023).","order":2,"name":"Ethics","label":"Human Ethics and consent to participate declarations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors declares any conflict of interest.","order":3,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"86"}}